Patents by Inventor Andrew Thorburn

Andrew Thorburn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating bladder cancer
    Patent number: 9321820
    Abstract: The present invention provides methods and compositions for treating bladder cancer. In particular, the present invention provides a fusion protein comprising a toxin moiety that is linked to an epithelial growth factor (EGF) moiety. The toxin moiety and the EGF moiety can be linked optionally via a linker. Typically, the fusion protein is administered intravesically into the cancerous bladder.
    Type: Grant
    Filed: October 14, 2010
    Date of Patent: April 26, 2016
    Assignees: The Regents of the University of Colorado, Scott & White Healthcare
    Inventors: Thomas Flaig, Arthur E. Frankel, Andrew Thorburn, Michael L. Glode
  • Methods for determining prognoses and therapeutic interventions for ovarian carcinomas
    Patent number: 8283119
    Abstract: Methods for determining the prognosis and therapeutic interventions for cancer and for utilizing the expression of the homeoprotein Six1 to determine the prognosis and therapeutic interventions for cancer, in particular for ovarian carcinomas.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: October 9, 2012
    Assignee: The Regents of the University of Colorado, A Body Corporate
    Inventors: Heide Ford, Kian Behbakht, Andrew Thorburn
  • Compositions and Methods for Treating Bladder Cancer
    Publication number: 20120232010
    Abstract: The present invention provides methods and compositions for treating bladder cancer. In particular, the present invention provides a fusion protein comprising a toxin moiety that is linked to an epithelial growth factor (EGF) moiety. The toxin moiety and the EGF moiety can be linked optionally via a linker. Typically, the fusion protein is administered intravesically into the cancerous bladder.
    Type: Application
    Filed: October 14, 2010
    Publication date: September 13, 2012
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventors: Thomas Flaig, Arthur E. Frankel, Andrew Thorburn, L.Michael Glode, Jung Hee Woo, David Neville
  • METHODS FOR DETERMINING PROGNOSES AND THERAPEUTIC INTERVENTIONS FOR OVARIAN CARCINOMAS
    Publication number: 20100099095
    Abstract: Methods for determining the prognosis and therapeutic interventions for cancer and for utilizing the expression of the homeoprotein Six1 to determine the prognosis and therapeutic interventions for cancer, in particular for ovarian carcinomas.
    Type: Application
    Filed: December 11, 2007
    Publication date: April 22, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Heide Ford, Kian Behbakht, Andrew Thorburn